Causes and consequences of anti-PEG antibodies

抗 PEG 抗体的原因和后果

• 批准号: 472917
• 负责人: Bertrand Nicolas
• 金额: $ 7.29万
• 依托单位: Universit Laval
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-09-01 至 2023-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=472917&lang=en
• 关键词: Lipid Nanoparticles; Mechanism Of Adverse Reactions; Mrna Vaccines; Nanomedicines; Poly(Ethylene Glycol)

The quick development of mRNA vaccines in response to the global SARS-CoV-2 pandemic has shown the promises of this technology. Now a manufacturing and regulatory precedent exists, it is likely that these technologies will become an important tool for fut

针对全球SARS-CoV-2大流行的mRNA疫苗的快速发展显示了这项技术的前景。现在有了制造和监管的先例，这些技术很可能成为未来的重要工具。